Summary
The antihypertensive effects of once-daily administration of celiprolol 400 mg were compared with those of once-daily enalapril 20 mg in 20 mild to moderate essential hypertensives in a single-blind study in which the subjects were randomized to 2 weeks' treatment with either drug, preceded by 2 weeks of placebo administration.
Supine and standing systolic blood pressure (SBP), diastolic pressure (DBP), and heart rate (HR) were measured at rest and during exercise (exercise bicycle with increasing work loads up to 100 watts) at the end of either period, 20 to 24 hr after drug or placebo administration.
Compared to placebo, both celiprolol and enalapril reduced resting supine and standing SBP and DBP to a marked and similar extent; resting HR was unaffected by enalapril, while celiprolol produced modest reductions.
During exercise, however, celiprolol significantly attenuated rises in SBP and HR, while enalapril did not.
Indexes of cardiac function at rest obtained by echocardiography and systolic time intervals were unaffected by either drug.
Thus, despite similar reductions by both drugs in resting blood pressures, celiprolol produced better antihypertensive effects during exercise than enalapril.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Caruso FS, Doshan HD, Hernandez PH, et al. Celiprolol: Pharmacokinetics and duration of pharmacodynamic activity Br J Clin Pract 39 1985; (Suppl 40):12–16.
Van Inwegen R, Khandwala A, Weinryb I, et al. Effects of celiprolol, a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis. Arch Int Pharmacodyn Ther 1984; 272:40–55.
Daul A. Wang XL, Borchard U, et al. Differential changes in lymphocyte β2-adrenoceptor density by β-blocker administration: Role of intrinsic sympathomimetic activity. J Cardiovasc Pharmacol 1986; 8 (Suppl 4):S93-S96.
Neve KA, Molinoff PB. Effects of chronic administration of agonists and antagonists on the density of β-adrenergic receptors. Am J Cardiol 1986; 57:17F-22F.
Schlevin HH, Barrett JA, Thomas GF, et al. Celiprolol HC1: Propranolol insensitive cardiostimulatory effects in anesthetized dogs. Pharmacologist 1983; 25:263–266.
Gensini G, Dator C, Esente P. et al. Comparison of the acute hemodynamic effects of intravenous celiprolol and propranolol in patients with suspected coronary disease. J Cardiovasc Pharmacol 1986; 8 (Suppl 4):S83-S85.
Mancia G, Grassi G, Parati G, et al. Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension. J Cardiovasc Pharmacol 1986; 8 (Suppl 4):S67-S74.
Ehringer H, Konecny U, Rasser W. The effect of celiprolol on peripheral circulation in healthy volunteers. Br J Clin Pract 1985; 39 (Suppl 40):91–99.
Matthys H. Einflusse von celiprolol, fenoterol und aminophyllin auf die atemwegsobstruktion im asthmaanfall. Schweiz Med Wochenschr 1982; 112:1849–1853.
Rosenthal RR, Doshan HD, Applin W, et al. The bronchosparing properties of celiprolol, a new cardioselective alpha-and beta-adrenoceptor blocking agent. J Clin Pharmacol 1984; 24:415–418.
Taylor SH, Beta-blocking drugs and myocardial function. J Cardiovasc Pharmacol 1986; 8 (Suppl 4):S75-S82.
Zilcher H, Ebm W, Knoflach P, et al. Treatment of essential hypertension with the β-receptor blocker celiprolol Arzneimitzeprorsch 1983; 33 (Suppl 1A):57–62.
Brunner HR, Waeber B, Nussberger J, et al. Long-term clinical experience with enalapril in essential hypertension. J Hypertens 1983; 1 (Suppl 1):103–107.
Weissler AM Harris WS, Schoenfeld CD. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 1969; 23:577–583.
Dunn OJ, Clark VA. Applied Statistics: Analysis of Variance and Regression. New York: Wiley, 1974.
Armitage P. Statistical Methods in Medical Research. New York: Wiley, 1971.
Tarazi RC, Bravo EL, Fouad FM, et al. Hemodynamic and volume changes associated with captopril. Hypertension 1980; 2:576–585.
Fouad FM, Tarazi RC, Bravo EL. Cardiac and hemodynamic effects of enalapril. J Hypertens 1983; 1 (Suppl 1):135–141.
Thadani U. Beta blockers in hypertension. Am J Cardiol 1983; 52:10D-15D.
Man In'T Veld AJ. Effect of beta blockers on vascular resistance in systemic hypertension. Am J Cardiol 1987; 59:21F-25F.
Hansson L. Zweiffler AJ, Julius S, Hunyor SN. Hemodynamic effects of acute and prolonged β-adrenergic blockade in essential hypertension. Acta Med Scand 1974; 196:27–34.
Maarek BL, Bouthier JA, Simon AC, et al. Comparative effects of propranolol and pindolol on small and large arteries and veins of the forearm circulation in hypertensive man. J Cadiovasc Pharmacol 1986; 8 (Suppl 4):S61-S66.
Reid JL, Millar JA, Campbell BC. Enalapril and automatic reflexes and exercise performance. J Hypertens 1983; 1 (Suppl 1):129–134.
Jones RI, Hornung RS, Cashman PMM, Raftery EB. Effect of enalapril at rest, during tilt, static and dynamic exercise in systemic hypertension. Am J Cardiol 1985; 55:1534–1538.
Pickering TG, Case DB, Sullivan PA, Laragh JH. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise. Am J Cardiol 1982; 49:1566–1568.
Pickering TG, Devereux RB. Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. Am Heart J 1987; 114:925–928.
Devereux RB, Pickering TG, Harshfield GA, et al. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress. Circulation 1983; 68:470–476.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghiringhelli, S., Cozzi, E. & Tsialtas, D. Hemodynamic effects of celiprolol at rest and during exercise; A comparison with enalapril. Cardiovasc Drug Ther 2, 211–218 (1988). https://doi.org/10.1007/BF00051236
Issue Date:
DOI: https://doi.org/10.1007/BF00051236